Citation only
via Europe PMC
Angiotensin II-induced hypertension does not exacerbate α-SYNUCLEIN pathology in a mouse model of Parkinson's disease.
Silva-Llanes I, Flores-Téllez D, Arrua WJ, El Jouhari NB, Oliver E, Martínez A, Briones AM, Lastres-Becker I.
Frontiers in immunology · 2026
Abstract
Parkinson's disease (PD) is characterized by progressive degeneration of nigrostriatal dopaminergic neurons accompanied by chronic neuroinflammation and α-SYNUCLEIN (α-SYN) aggregation. Increasing evidence suggests that cardiovascular comorbidities, including arterial hypertension, may contribute to neurodegenerative processes through vascular dysfunction and sustained inflammatory signaling. However, whether hypertension directly exacerbates α-SYN-induced neurodegeneration and inflammasome activation remains unclear. Here, we investigated the impact of chronic Angiotensin II (AngII)-induced hypertension in an adeno-associated viral vector (AAV)-based mouse model of PD driven by unilateral overexpression of human α-SYN in the <i>Substantia Nigra</i> (SN). Chronic AngII infusion produced a robust hypertensive phenotype but did not aggravate α-SYN-induced loss of tyrosine hydroxylase-positive dopaminergic neurons. Similarly, hypertension failed to modify α-SYN-driven astrogliosis, microgliosis, or microglial morphological activation. Molecular analyses revealed that α-SYN overexpression markedly increased the expression of inflammatory mediators and pyroptosis-related genes, including <i>Nlrp3</i>, <i>Asc</i>, <i>Casp1</i>, <i>Il1b</i>, <i>Il18rap</i>, and <i>Gsdmd</i>. Nevertheless, hypertension did not potentiate these responses. Immunofluorescence analyses further demonstrated that GSDMD expression was predominantly localized in IBA1-positive microglial cells and was significantly elevated following α-SYN overexpression independently of hypertensive status. Collectively, these findings indicate that chronic AngII-induced hypertension is insufficient to exacerbate early α-SYN-mediated neurodegeneration, gliosis, or inflammasome-associated pyroptotic pathways in the SN. Our study suggests that α-SYN pathology itself constitutes the dominant driver of neuroinflammatory activation in this experimental paradigm and that additional vascular or aging-related mechanisms may be required for hypertension to significantly influence PD progression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fimmu.2026.1894579
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
I, S., D, F., WJ, A., NB, E.J., E, O., A, M., AM, B., & I., L. (2026). Angiotensin II-induced hypertension does not exacerbate α-SYNUCLEIN pathology in a mouse model of Parkinson's disease. <em>Frontiers in immunology</em>. https://doi.org/10.3389/fimmu.2026.1894579
Vancouver
I S, D F, WJ A, NB EJ, E O, A M, et al. Angiotensin II-induced hypertension does not exacerbate α-SYNUCLEIN pathology in a mouse model of Parkinson's disease. Frontiers in immunology. 2026. doi:10.3389/fimmu.2026.1894579.
BibTeX
@article{silvallanes2026Angiot,
title = {Angiotensin II-induced hypertension does not exacerbate α-SYNUCLEIN pathology in a mouse model of Parkinson's disease.},
author = {Silva-Llanes I and Flores-Téllez D and Arrua WJ and El Jouhari NB and Oliver E and Martínez A and Briones AM and Lastres-Becker I.},
journal = {Frontiers in immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1894579},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Molecular Neuroscience 2023
Open access · CC-BY
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Acta Neuropathologica Communications 2014
Open access · CC-BY
Models of α-synuclein aggregation in Parkinson’s disease
Brain 2023
Open access · CC-BY
Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease
Cells 2019
Open access · CC-BY
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Journal of Clinical Investigation 2015
Open access · OA
shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model
Journal of Neuroinflammation 2019
Open access · CC-BY